Ftse Mib
37.908,05
1,00%
DAX
22.612,02
2,12%
S&P 500
6.115,07
1,04%
NASDAQ
19.945,64
1,50%
Bitcoin
96.600,86
-0,02%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MeiraGTx Holdings PLC (MGTX) MeiraGTx Holdings PLC (MGTX) Notizie

MGTX

MeiraGTx (MGTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MGTX
DataOraFonteTitoloSimboloCompagnia
22/01/202514:30GlobeNewswire Inc.MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D MutationsNASDAQ:MGTXMeiraGTx Holdings PLC
22/01/202503:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTXMeiraGTx Holdings PLC
22/01/202502:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGTXMeiraGTx Holdings PLC
09/12/202415:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTXMeiraGTx Holdings PLC
09/12/202414:00GlobeNewswire Inc.MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced XerostomiaNASDAQ:MGTXMeiraGTx Holdings PLC
25/11/202401:27PR Newswire (US)Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive DirectorsNASDAQ:MGTXMeiraGTx Holdings PLC
13/11/202414:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTXMeiraGTx Holdings PLC
13/11/202414:00GlobeNewswire Inc.MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business UpdatesNASDAQ:MGTXMeiraGTx Holdings PLC
22/10/202414:00GlobeNewswire Inc.MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual CongressNASDAQ:MGTXMeiraGTx Holdings PLC
15/10/202413:00GlobeNewswire Inc.MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s DiseaseNASDAQ:MGTXMeiraGTx Holdings PLC
09/10/202422:30GlobeNewswire Inc.MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience ConferenceNASDAQ:MGTXMeiraGTx Holdings PLC
12/08/202423:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MGTXMeiraGTx Holdings PLC
12/08/202413:05GlobeNewswire Inc.MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
12/08/202413:03GlobeNewswire Inc.MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by SanofiNASDAQ:MGTXMeiraGTx Holdings PLC
09/05/202414:00GlobeNewswire Inc.MeiraGTx Reports First Quarter 2024 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
24/04/202422:30GlobeNewswire Inc.MeiraGTx to Participate in Upcoming Investor ConferencesNASDAQ:MGTXMeiraGTx Holdings PLC
18/04/202422:30GlobeNewswire Inc.MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual ConferenceNASDAQ:MGTXMeiraGTx Holdings PLC
14/03/202413:30GlobeNewswire Inc.MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business UpdatesNASDAQ:MGTXMeiraGTx Holdings PLC
13/02/202414:00GlobeNewswire Inc.MeiraGTx Announces $50 Million Milestone from Janssen PharmaceuticalsNASDAQ:MGTXMeiraGTx Holdings PLC
09/02/202416:10Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGTXMeiraGTx Holdings PLC
18/01/202423:17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MGTXMeiraGTx Holdings PLC
02/01/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTXMeiraGTx Holdings PLC
21/12/202314:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGTXMeiraGTx Holdings PLC
21/12/202313:00GlobeNewswire Inc.MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 millionNASDAQ:MGTXMeiraGTx Holdings PLC
14/11/202314:00GlobeNewswire Inc.MeiraGTx Announces Third Quarter 2023 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
30/10/202313:14Dow Jones NewsMeiraGTx Gets $30 Million Investment From SanofiNASDAQ:MGTXMeiraGTx Holdings PLC
30/10/202312:30GlobeNewswire Inc.MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic OpportunitiesNASDAQ:MGTXMeiraGTx Holdings PLC
24/10/202314:30GlobeNewswire Inc.MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual CongressNASDAQ:MGTXMeiraGTx Holdings PLC
10/08/202314:00GlobeNewswire Inc.MeiraGTx Reports Second Quarter 2023 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
01/08/202315:10GlobeNewswire Inc.MeiraGTx Announces Poster Presentation at the 2023 American Society of Gene and Cell Therapy (ASGCT) Spotlight on Immuno-OncologyNASDAQ:MGTXMeiraGTx Holdings PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MGTX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
TIT
Telecom Italia
BIT
ISP
Intesa Sanpaolo
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
RACE
Ferrari NV
BIT
CPR
Davide Campari
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
NEXI
Nexi S.p.A
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
TITR
Telecom Italia
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci